RVTY Stock Overview
Provides health sciences solutions, technologies, and services worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Revvity, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$93.43 |
| 52 Week High | US$129.50 |
| 52 Week Low | US$88.53 |
| Beta | 1.07 |
| 1 Month Change | -11.69% |
| 3 Month Change | -26.34% |
| 1 Year Change | -8.94% |
| 3 Year Change | -40.52% |
| 5 Year Change | 0.18% |
| Change since IPO | 2,720.53% |
Recent News & Updates
Recent updates
Calculating The Fair Value Of Revvity, Inc. (NYSE:RVTY)
Apr 25
Why We're Not Concerned About Revvity, Inc.'s (NYSE:RVTY) Share Price
Apr 07Should You Think About Buying Revvity, Inc. (NYSE:RVTY) Now?
Mar 20Revvity: Acquisitions In High-Growth Sectors, Excellent Debt Levels Create Notable Growth Potential
Feb 24Does Revvity (NYSE:RVTY) Have A Healthy Balance Sheet?
Feb 11Shareholders Should Be Pleased With Revvity, Inc.'s (NYSE:RVTY) Price
Jan 06Why Revvity, Inc. (NYSE:RVTY) Could Be Worth Watching
Dec 19Safe Biopharma: Revvity's Recurring Revenues And Diagnostics
Dec 16Estimating The Intrinsic Value Of Revvity, Inc. (NYSE:RVTY)
Dec 01We Think Revvity's (NYSE:RVTY) Healthy Earnings Might Be Conservative
Nov 13Here's Why Revvity (NYSE:RVTY) Can Manage Its Debt Responsibly
Oct 24Getting In Cheap On Revvity, Inc. (NYSE:RVTY) Might Be Difficult
Aug 21
Share Repurchases And AI Integration Propel Earnings And Revolutionize Diagnostics Growth
Aug 21 Aggressive share repurchase and implementation of AI-driven technologies could enhance shareholder value and operational efficiencies, leading to potential revenue growth.When Should You Buy Revvity, Inc. (NYSE:RVTY)?
Jul 16Revvity: Continued Struggles, 2024 Becoming A Lost Year
Jul 03Is Revvity (NYSE:RVTY) Using Too Much Debt?
Jun 10Revvity: Enter Now As Reorganization Takes Shape
Mar 21Revvity: More Than A Name Change Is Needed For PerkinElmer
Dec 29Shareholder Returns
| RVTY | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | -0.3% | 0.6% | 2.7% |
| 1Y | -8.9% | -25.8% | 9.6% |
Return vs Industry: RVTY exceeded the US Life Sciences industry which returned -25.4% over the past year.
Return vs Market: RVTY underperformed the US Market which returned 9.9% over the past year.
Price Volatility
| RVTY volatility | |
|---|---|
| RVTY Average Weekly Movement | 6.0% |
| Life Sciences Industry Average Movement | 10.7% |
| Market Average Movement | 7.8% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 4.1% |
Stable Share Price: RVTY has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: RVTY's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1937 | 11,000 | Prahlad Singh | www.revvity.com |
Revvity, Inc. provides health sciences solutions, technologies, and services worldwide. The company’s Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and DNA sequencing services. Its Diagnostics segment offers instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Revvity, Inc. Fundamentals Summary
| RVTY fundamental statistics | |
|---|---|
| Market cap | US$11.37b |
| Earnings (TTM) | US$296.04m |
| Revenue (TTM) | US$2.77b |
37.9x
P/E Ratio4.1x
P/S RatioIs RVTY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RVTY income statement (TTM) | |
|---|---|
| Revenue | US$2.77b |
| Cost of Revenue | US$1.21b |
| Gross Profit | US$1.56b |
| Other Expenses | US$1.26b |
| Earnings | US$296.04m |
Last Reported Earnings
Mar 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.46 |
| Gross Margin | 56.25% |
| Net Profit Margin | 10.69% |
| Debt/Equity Ratio | 41.5% |
How did RVTY perform over the long term?
See historical performance and comparisonDividends
0.3%
Current Dividend Yield12%
Payout RatioDoes RVTY pay a reliable dividends?
See RVTY dividend history and benchmarks| Revvity dividend dates | |
|---|---|
| Ex Dividend Date | Apr 17 2025 |
| Dividend Pay Date | May 09 2025 |
| Days until Ex dividend | 14 days |
| Days until Dividend pay date | 8 days |
Does RVTY pay a reliable dividends?
See RVTY dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/30 05:58 |
| End of Day Share Price | 2025/04/30 00:00 |
| Earnings | 2025/03/30 |
| Annual Earnings | 2024/12/29 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Revvity, Inc. is covered by 39 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Catherine Ramsey Schulte | Baird |
| Luke Sergott | Barclays |
| Charles Butler | Barclays |